LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 161 filers reported holding LEGEND BIOTECH CORP in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,781,660 | -2.7% | 458,265 | 0.0% | 0.82% | +9.6% |
| Q2 2023 | $31,634,033 | +43.2% | 458,265 | 0.0% | 0.75% | +42.9% |
| Q1 2023 | $22,097,538 | -1.7% | 458,265 | +1.7% | 0.53% | -2.6% |
| Q4 2022 | $22,487,263 | +22.4% | 450,466 | 0.0% | 0.54% | +13.9% |
| Q3 2022 | $18,379,000 | -6.0% | 450,466 | +26.7% | 0.48% | -16.5% |
| Q2 2022 | $19,556,000 | +30.9% | 355,567 | -13.5% | 0.57% | +51.3% |
| Q1 2022 | $14,942,000 | -20.6% | 411,184 | +1.9% | 0.38% | -13.6% |
| Q4 2021 | $18,811,000 | +18.0% | 403,584 | +28.0% | 0.44% | +29.9% |
| Q3 2021 | $15,937,000 | +24.2% | 315,218 | +0.8% | 0.34% | +31.9% |
| Q2 2021 | $12,833,000 | +41.5% | 312,618 | 0.0% | 0.25% | +28.3% |
| Q1 2021 | $9,072,000 | +4.1% | 312,618 | +1.0% | 0.20% | +7.0% |
| Q4 2020 | $8,713,000 | +11.9% | 309,418 | +22.7% | 0.18% | -6.6% |
| Q3 2020 | $7,784,000 | -11.2% | 252,138 | +22.5% | 0.20% | -17.5% |
| Q2 2020 | $8,763,000 | – | 205,896 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 997,714 | $36,257,000 | 13.28% |
| JOHNSON & JOHNSON | 1,629,173 | $59,204,000 | 11.19% |
| Paradigm Biocapital Advisors LP | 831,728 | $30,225,000 | 7.99% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,100,542 | $39,994,000 | 5.54% |
| HHLR ADVISORS, LTD. | 6,936,617 | $252,077,000 | 5.26% |
| Old Well Partners, LLC | 79,700 | $2,896,000 | 1.94% |
| Parkman Healthcare Partners LLC | 120,473 | $4,378,000 | 1.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 4,500 | $5,632,000 | 1.27% |
| AtonRa Partners | 50,928 | $1,851,000 | 1.00% |
| Avidity Partners Management LP | 1,095,000 | $39,792,000 | 0.83% |